These applications seek to: (a) reduce and prevent diseases and disability; (b) improve diagnosis, treatment, and management of chronic diseases and developmental disorders, including consideration of socioeconomic, organizational and demographic factors; (c) enhance protective factors and coping abilities; d) modify health behaviors to reduce risk and maximize well-being; and, e) test emergent technologies to support clinical decision-making for chronic disease conditions and behavioral outcomes. Novel technologies, interventions, tools, and approaches that may include mobile and e-health apps and platforms, artificial intelligence, assessment instruments, serious games, educational software and curricula, virtual and augmented reality, sensors, monitors, and other user-oriented devices, across different subgroups, are reviewed in this panel.

 

The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.

Review Dates

Topics


  • Interventions to promote health-seeking and disease prevention behaviors, including education, communication and screening.
  • Technologies aimed at preventing or reducing addiction and risky behaviors, including smoking, drug, and alcohol abuse.
  • Strategies, tools, and complementary and alternative approaches to increasing physical activity, improving diet and nutrition, reducing obesity, and managing chronic health conditions, including cardiovascular disease, cancer, asthma and diabetes.
  • Tools to improve therapeutic safety, enhance patient-provider communication, monitor compliance/adherence and inform decision-making for chronic illness and pain management at the individual and institutional levels.
  • Educational and outreach tools to increase access and reduce disparities in health services utilization.
  • Training and support for caregivers and individuals with chronic diseases and disorders.

Shared Interests and Overlaps

Small Business: Psycho/Neuropathology, Lifespan Development and STEM Education (RPHB (12)) : RPHB 10 and RPHB 12 have a shared focus in applications on human health and behavioral intervention and prevention. Applications are reviewed in RPHB 10 if they are related to health behavior and disease risk (cardiovascular, weight/obesity, etc.), addictions, health services, health disparities and provider training. Applications are reviewed in RPHB 12 if they are related to psychosocial and neuro-developmental functioning and general science education.

Healthcare Delivery and Methodologies IRG (HDM): RPHB 10 and HDM have a shared focus in applications on human health and health informatics. Applications are assigned to HDM if they are related to data collection, statistical methods, and large-scale integration with providers, libraries, and institutions. Applications are reviewed in RPHB 10 if they involve provider training or use of new approaches, including artificial intelligence and data integration, to induce health behavioral change, reduce health risks or improve clinical effectiveness.

Interdisciplinary Molecular Sciences and Training IRG (IMST): RPHB 10 and IMST have a shared interest in applications on bioengineering devices and technologies. Applications are reviewed in IMST if they are related to diagnostic technologies, imaging and drug delivery devices, classification systems, sensors for monitoring and measuring health, adherence, or the environment, multi-mics and biomarkers. Applications are reviewed in RPHB 10 if they involve the use of biomedical engineering to influence health risks and behaviors.

Musculoskeletal, Oral and Skin Sciences IRG (MOSS): RPHB 10 and MOSS have a shared interest in applications regarding musculoskeletal, oral and dermatological health. Applications involving rheumatology, musculoskeletal rehabilitation and orthopedic techniques and devices are reviewed in MOSS. Applications related to physical functioning from the perspective of devices for personal medical use and measurement are reviewed in RPHB 10.